Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
01 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
02 Executive Summary
03 Biobanking Market Overview
3.1 Latin America Biobanking Market
3.1.1 Latin America Biobanking Market Historical Value (2019-2025)
3.1.2 Latin America Biobanking Market Forecast Value (2026-2035)
3.2 Mexico Biobanking Market
3.2.1 Mexico Biobanking Market Historical Value (2019-2025)
3.2.2 Mexico Biobanking Market Forecast Value (2026-2035)
04 Mexico Biobanking Market Landscape*
4.1 Mexico Biobanking Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Mexico Biobanking Market: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Storage Type
4.2.3 Analysis by Ownership
05 Mexico Biobanking Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter’s Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
06 Mexico Biobanking Market Segmentation (2019-2035)
6.1 Mexico Biobanking Market (2019-2035) by Type
6.1.1 Equipment
6.1.1.1 Storage Equipment
6.1.1.2 Sample Analysis Equipment
6.1.1.3 Sample Processing Equipment
6.1.1.4 Sample Transport Equipment
6.1.2 Consumables
6.1.2.1 Storage Consumables
6.1.2.2 Analysis Consumables
6.1.2.3 Processing Consumables
6.1.2.4 Collection Consumables
6.1.3 Services
6.1.3.1 Storage Services
6.1.3.2 Processing Services
6.1.3.3 Transport Services
6.1.3.4 Supply Services
6.1.4 Software
6.2 Mexico Biobanking Market (2019-2035) by Storage Type
6.2.1 Manual Storage
6.2.2 Automated Storage
6.3 Mexico Biobanking Market (2019-2035) by Sample Type
6.3.1 Blood Products
6.3.2 Human Tissues
6.3.3 Cell Lines
6.3.4 Nucleic Acid
6.3.5 Human Waste Products
6.3.6 Others
6.4 Mexico Biobanking Market (2019-2035) by Ownership
6.4.1 Universities
6.4.2 National/Regional Agencies
6.4.3 Non-Profit Organizations
6.4.4 Private Organizations
6.5 Mexico Biobanking Market (2019-2035) by Application
6.5.1 Regenerative Medicine
6.5.2 Life Science Research
6.5.3 Clinical Research
6.6 Mexico Biobanking Market (2019-2035) by End User
6.6.1 Pharmaceutical and Biotechnological Companies
6.6.2 Hospital and Healthcare Providers
6.6.3 Academic and Research Institutes
6.6.4 Other End Users
07 Regulatory Framework
08 Funding and Investment Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
09 Strategic Initiatives
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Initiatives
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Supplier Landscape
10.1 Market Share Analysis
10.2 Thermo Fisher Scientific Inc.
10.2.1 Financial Analysis
10.2.2 Product/Service Portfolio
10.2.3 Demographic Reach and Achievements
10.2.4 Company News and Developments
10.2.5 Certifications
10.3 PHC Holdings Corporation
10.3.1 Financial Analysis
10.3.2 Product/Service Portfolio
10.3.3 Demographic Reach and Achievements
10.3.4 Company News and Developments
10.3.5 Certifications
10.4 Qiagen N.V.
10.4.1 Financial Analysis
10.4.2 Product/Service Portfolio
10.4.3 Demographic Reach and Achievements
10.4.4 Company News and Developments
10.4.5 Certifications
10.5 Tecan Group Ltd.
10.5.1 Financial Analysis
10.5.2 Product/Service Portfolio
10.5.3 Demographic Reach and Achievements
10.5.4 Company News and Developments
10.5.5 Certifications
10.6 Becton, Dickinson and Company (BD)
10.6.1 Financial Analysis
10.6.2 Product/Service Portfolio
10.6.3 Demographic Reach and Achievements
10.6.4 Company News and Developments
10.6.5 Certifications
10.7 Merck KGaA
10.7.1 Financial Analysis
10.7.2 Product/Service Portfolio
10.7.3 Demographic Reach and Achievements
10.7.4 Company News and Developments
10.7.5 Certifications
10.8 Avantor, Inc.
10.8.1 Financial Analysis
10.8.2 Product/Service Portfolio
10.8.3 Demographic Reach and Achievements
10.8.4 Company News and Developments
10.8.5 Certifications
10.9 Cryoport Inc.
10.9.1 Financial Analysis
10.9.2 Product/Service Portfolio
10.9.3 Demographic Reach and Achievements
10.9.4 Company News and Developments
10.9.5 Certifications
10.10 Azenta Inc.
10.10.1 Financial Analysis
10.10.2 Product/Service Portfolio
10.10.3 Demographic Reach and Achievements
10.10.4 Company News and Developments
10.10.5 Certifications
10.11 Greiner AG
10.11.1 Financial Analysis
10.11.2 Product/Service Portfolio
10.11.3 Demographic Reach and Achievements
10.11.4 Company News and Developments
10.11.5 Certifications
11 Mexico Biobanking Market – Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment
12 Key Opinion Leaders (KOL) Insights (Additional Insight)